TAS6417
Zipalertinib (TAS6417, CLN-081) is a potent, orally bioavailable covalent EGFR inhibitor targeting the ATP-binding hinge region with low nM IC50 values. It is a research tool for investigating EGFR-driven cancers, demonstrating activity in both cellular assays and in vivo tumor models.
Product Specifications
CAS Number
1661854-97-2
Product Name Alternative
Lung, inhibit, PC-9, NSCLC, H1975, ErbB-1, Epidermal growth factor receptor, EGFR, HER1, Inhibitor, Akt, Apoptosis, BID007, BID019, BEAS-2B, cancer, CLN081, CLN-081, CLN 081, TAS6417, TAS-6417, TAS 6417
Field of Research
Cardiovascular Research, Cell Biology, Signal Transduction
Purity
99.19% (May vary between batches)
Solubility
DMSO:55 mg/mL (138.73 mM) ;10% DMSO+40% PEG300+5% Tween-80+45% Saline:2.5 mg/mL (6.31 mM)
Smiles
CC1=C[C@@H] (Cn2c1c (-c1cnc3ccccc3c1) c1c (N) ncnc21) NC (=O) C=C
Molecular Formula
C23H20N6O
Molecular Weight
396.44
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
128539-ML550 100 µL
Interleukin 18BP (Interleukin 18 Binding Protein, IL-18BP, IL18BP, IL18BPa, Tadekinig-alfa, Interleukin-18-binding Protein) (MaxLight 550)
Sign In for Pricing
View Details C2562-05C-01 100 µg
Cdc37, Recombinant Human, aa1-378 (S. cerevisiae hypothetical protein CDC37, CDC37 cell division cycle 37 homolog, Cdc37, Hsp90 chaperone protein kinase targeting subunit, Hsp90 p50Cdc37, co chaperone Cdc37, p50Cdc37)
Sign In for Pricing
View Details